構造的心疾患（SHD）カテーテル治療の多施設レジストリーグループ『OCEAN-SHD研究会』
Optimized CathEter vAlvular iNtervention Structual Heart Disease

youtube
instagram
facebook

論文実績

 
 

2021年

Successfully Managed Access-Site Complication Was Not Associated With Worse Outcome After Percutaneous Transfemoral Transcatheter Aortic Valve Implantation: Up-to-Date Insights From the OCEAN-TAVI Registry

Yohsuke Honda

Saiseikai Yokohama City Eastern Hospital

Impact of New York Heart AsImpact of New York Heart Association Functional Class on Outcomes After Transcatheter Aortic Valve Implantationsociation Functional Class on Outcomes After Transcatheter Aortic Valve Implantation

Tomohiko Taniguchi

Kokura Memorial Hospital

Risk assessment in patients with left ventricular systolic dysfunction following transcatheter aortic valve replacement

Teruhiko Imamura

University of Toyama

Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement

Tetsuro Shimura

Toyohashi Heart Center

Statin therapy for patients with aortic stenosis who underwent transcatheter aortic valve implantation: a report from a Japanese multicentre registry

Fumiaki Yashima

Saiseikai Utsunomiya Hospital

Balloon post-dilatation improves long-term valve performance after balloon-expandable valve implantation.

Yugo Nara

Teikyo University

Comparison of long-term mortality in patients who underwent transcatheter aortic valve replacement with or without anti-atherosclerotic therapy

Kazuya Sasaki

Teikyo University

Reply: DOACs for AF After TAVR: Are DOACs Really on First Base?

Hideyuki Kawashima

Teikyo University School of Medicine

Creatinine Score Can Predict Persistent Renal Dysfunction Following Trans-Catheter Aortic Valve Replacement

Teruhiko Imamura

University of Toyama.

Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry

Yusuke Kobari

Keio University School of Medicine

Effect of Sex on Mortality and Left Ventricular Remodeling After Transcatheter Aortic Valve Implantation

Koki Shishido

Shonan Kamakura General Hospital

Identification of Anemia for Predicting Mid-Term Prognosis After Transcatheter Aortic Valve Implantation in Japanese Patients　― Insights From the OCEAN-TAVI Registry ―

Hiroshi Onoda

University of Toyama

Long-Term Prognostic Value of the Society of Thoracic Surgery Risk Score in Patients Undergoing Transcatheter Aortic Valve Implantation

Kenichi Ishizu

Kokura Memorial Hospital

Small Left Ventricle and Clinical Outcomes After Transcatheter Aortic Valve Replacement

Tetsuya Saito

Keio University School of Medicine

Incidence and predictors of prosthesis-patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve

Masaki Miyasaka

Sendai Kosei Hospital

Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement

Tetsuro Shimura

Toyohashi Heart Center

Clinical Outcomes of Subcutaneous and Visceral Adipose Tissue Characteristics Assessed in Patients Underwent Transcatheter Aortic Valve Replacement

Kenichi Shibata

Nagoya Heart Canter

Late kidney injury after transcatheter aortic valve replacement

Yuya Adachi

Toyohashi Heart Center

 

2020年

Patients’ characteristics and mortality in urgent/emergent/salvage transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry

Yusuke Enta

Sendai Kousei Hospital

The Impact of Baseline Thrombocytopenia on Late Bleeding and Mortality After Transcatheter Aortic Valve Implantation (From the Japanese Multicenter OCEAN-TAVI Registry)

Shinya Ito

Kokura Memorial Hospital

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR

Hideyuki Kawashima

Teikyo University School of Medicine

Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN-TAVI registry

Hiromu Hase

Keio University School of Medicine

Predictors and Prognostic Impact of Nutritional Changes After Transcatheter Aortic Valve Replacement

Tetsuro Shimura

Toyohashi Heart Center

Short-term dual antiplatelet therapy decreases long-term cardiovascular mortality after transcatheter aortic valve replacement

Hirofumi Hioki

Teikyo University Hospital

Midterm outcomes after the rescue THV-in-THV procedure: Insights
from the multicenter prospective OCEAN-TAVI registry

Makoto Hibino

Tokyo Bay Urayasu-Ichikawa Medical Center

Clinical risk model for predicting 1-year mortality after transcatheter aortic valve replacement

Masanori Yamamoto

Toyohashi Heart Center

Late Adverse Cardiorenal Events of Catheter Procedure-Related Acute Kidney Injury After Transcatheter Aortic Valve Implantation

Yuya Adachi

Toyohashi Heart Center

Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry.

Tetsuya Saito

Keio University School of Medicine

A novel technique to avoid perforation of the right ventricle by the temporary pacing lead during transcatheter aortic valve implantation.

Makoto Tanaka

Keio University School of Medicine

Evaluation of the incidence, timing, and potential recovery rates of complete atrioventricular block after transcatheter aortic valve implantation: a Japanese multicenter registry study.

Ai Kagase

Toyohashi Heart Canter

Clinical outcomes of transcatheter aortic valve implantation (TAVI) in nonagenarians from the optimized catheter valvular intervention-TAVI registry

Masahiko Noguchi

Tokyo Bay Urayasu Ichikawa Medical Center

Appropriateness of Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.

Taku Inohara

Keio University School of Medicine

Importance of combined assessment of skeletal muscle mass and density by computed tomography in predicting clinical outcomes after transcatheter aortic valve replacement

Takahiro Tokuda

Nagoya Heart Center

 

2019年

  1. Miura M, Yamaji K, Shirai S, Hayashi M, Kawaguchi T, Arai Y, Sakaguchi G, Ando K, Naganuma T, Mizutani K, Araki M, Tada N, Yamanaka F, Tabata M, Ueno H, Takagi K, Higashimori A, Watanabe Y, Yamamoto M, Hayashida K; of the OCEAN-TAVI Investigators. Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve Replacement. Can J Cardiol. 2020 Jul;36(7):1112-1120. doi: 10.1016/j.cjca.2019.12.022. Epub 2019 Dec 31. PMID: 32470334
  2. Tsunaki T, Yamamoto M, Shimura T, Kagase A, Naganuma T, Higashimori A, Araki M, Yamanaka F, Mizutani K, Watanabe Y, Otsuka T, Yanagisawa R, Hayashida K. Silent Valsalva thrombus between the native Valsalva and balloon-expandable transcatheter heart valve: multicentre Japanese registry analysis. EuroIntervention. 2019 Nov 20;15(10):892-899. doi: 10.4244/EIJ-D-19-00370. PMID: 31746754
  3. Yamamoto M, Kagase A, Shimura T, Koyama Y, Tsujimoto S, Kano S, Hosoba S, Tada N, Yamanaka F, Naganuma T, Araki M, Shirai S, Mizutani K, Tabata M, Ueno H, Takagi K, Higashimori A, Watanabe Y, Hayashida K; OCEAN-TAVI investigators. Percutaneous Aortic Valve Intervention in Patients Scheduled for Noncardiac Surgery: A Japanese Multicenter Study. Cardiovasc Revasc Med. 2020 May;21(5):621-628. doi: 10.1016/j.carrev.2019.09.023. Epub 2019 Oct 22. PMID: 32005595
  4. Tanaka M, Yanagisawa R, Yashima F, Arai T, Jinzaki M, Shimizu H, Fukuda K, Watanabe Y, Naganuma T, Shirai S, Araki M, Tada N, Yamanaka F, Higashimori A, Takagi K, Ueno H, Tabata M, Mizutani K, Yamamoto M, Hayashida K; OCEAN-TAVI investigators. Previously implanted mitral surgical prosthesis in patients undergoing transcatheter aortic valve implantation: Procedural outcome and morphologic assessment using multidetector computed tomography. PLoS One. 2019 Dec 26;14(12):e0226512. doi: 10.1371/journal.pone.0226512. eCollection 2019. PMID: 31877159
  5. Takagi K, Naganuma T, Tada N, Yamanaka F, Araki M, Shirai S, Higashimori A, Watanabe Y, Yamamoto M, Hayashida K. The Predictors of Peri-Procedural and Sub-Acute Cerebrovascular Events Following TAVR from OCEAN-TAVI Registry. Cardiovasc Revasc Med. 2020 Jun;21(6):732-738. doi: 10.1016/j.carrev.2019.10.013. Epub 2019 Oct 31. PMID: 31761635
  6. Nara Y, Kataoka A, Watanabe Y, Makoto N, Hioki H, Kawashima H, Fukuko N, Kozuma K, Shirai S, Tada N, Araki M, Naganuma T, Yamanaka F, Ueno H, Tabata M, Mizutani K, Higashimori A, Takagi K, Yamamoto M, Hayashida K. Prognostic impact of postprocedure stroke volume in patients with low-gradient aortic stenosis. Open Heart. 2019 May 24;6(1):e000988. doi: 10.1136/openhrt-2018-000988. eCollection 2019. PMID: 31218001
  7. Hioki H, Watanabe Y, Kozuma K, Kawashima H, Nagura F, Nakashima M, Kataoka A, Yamamoto M, Naganuma T, Araki M, Tada N, Shirai S, Yamanaka F, Higashimori A, Mizutani K, Tabata M, Takagi K, Ueno H, Hayashida K. The MAGGIC risk score predicts mortality in patients undergoing transcatheter aortic valve replacement: sub-analysis of the OCEAN-TAVI registry. Heart Vessels. 2019 Dec;34(12):1976-1983. doi: 10.1007/s00380-019-01443-9. Epub 2019 May 29. PMID: 31144098
  8. Koyama Y, Yamamoto M, Kagase A, Tsujimoto S, Kano S, Shimura T, Hosoba S, Watanabe Y, Tada N, Naganuma T, Araki M, Yamanaka F, Mizutani K, Tabata M, Ueno H, Takagi K, Higashimori A, Shirai S, Hayashida K. Prognostic impact and periprocedural complications of chronic steroid therapy in patients following transcatheter aortic valve replacement: Propensity-matched analysis from the Japanese OCEAN registry. Catheter Cardiovasc Interv. 2020 Mar 1;95(4):793-802. doi: 10.1002/ccd.28332. Epub 2019 May 21. PMID: 31112003
  9. Yoshijima N, Yanagisawa R, Hase H, Tanaka M, Tsuruta H, Shimizu H, Fukuda K, Naganuma T, Mizutani K, Araki M, Tada N, Yamanaka F, Shirai S, Tabata M, Ueno H, Takagi K, Higashimori A, Watanabe Y, Yamamoto M, Hayashida K; OCEAN-TAVI investigators. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry. Catheter Cardiovasc Interv. 2020 Jan;95(1):35-44. doi: 10.1002/ccd.28279. Epub 2019 Apr 11. PMID: 30977256
  10. Yanagisawa R, Tanaka M, Yashima F, Arai T, Jinzaki M, Shimizu H, Fukuda K, Watanabe Y, Naganuma T, Higashimori A, Mizutani K, Araki M, Tada N, Yamanaka F, Otsuka T, Yamamoto M, Hayashida K. Early and Late Leaflet Thrombosis After Transcatheter Aortic Valve Replacement. Circ Cardiovasc Interv. 2019 Feb;12(2):e007349. doi: 10.1161/CIRCINTERVENTIONS.118.007349. PMID: 30732472
  11. Nagura F, Kataoka A, Hara M, Kozuma K, Watanabe Y, Nakashima M, Hioki H, Kawashima H, Nara Y, Shirai S, Tada N, Araki M, Naganuma T, Yamanaka F, Ueno H, Tabata M, Mizutani K, Higashimori A, Takagi K, Yamamoto M, Hayashida K; OCEAN-TAVI investigators. Association between valvuloarterial impedance after transcatheter aortic valve implantation and 2-year mortality in elderly patients with severe symptomatic aortic stenosis: the OCEAN-TAVI registry. Heart Vessels. 2019 Jun;34(6):1031-1039. doi: 10.1007/s00380-018-01329-2. Epub 2019 Jan 1. PMID: 30599060
 

2018年

  1. Yamamoto M, Watanabe Y, Tada N, Naganuma T, Araki M, Yamanaka F, Mizutani K, Tabata M, Ueno H, Takagi K, Higashimori A, Shirai S, Hayashida K; OCEAN-TAVI investigators. Transcatheter aortic valve replacement outcomes in Japan: Optimized CathEter vAlvular iNtervention (OCEAN) Japanese multicenter registry. Cardiovasc Revasc Med. 2019 Oct;20(10):843-851. doi: 10.1016/j.carrev.2018.11.024. Epub 2018 Dec 4. PMID: 30553819
  2. Kataoka A, Watanabe Y, Shibayama K, Mizutani K, Naganura T, Higashimori A, Ueno H, Yamanaka F, Takagi K, Araki M, Tada N, Shirai S, Yamamoto M, Hayashida K; OCEAN-TAVI Investigators. Reasons for Not Performing Low-Dose Dobutamine Stress Echocardiography in Patients with Classical Low-Flow, Low-Gradient Severe Aortic Stenosis Before Transcatheter Aortic Valve Replacement: The Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation Registry. J Am Soc Echocardiogr. 2018 Dec;31(12):1366-1368. doi: 10.1016/j.echo.2018.09.005. Epub 2018 Oct 16. PMID: 30340891
  3. Shimura T, Yamamoto M, Kano S, Hosoba S, Sago M, Kagase A, Koyama Y, Tsujimoto S, Otsuka T, Tada N, Naganuma T, Araki M, Yamanaka F, Shirai S, Mizutani K, Tabata M, Ueno H, Takagi K, Higashimori A, Watanabe Y, Hayashida K; OCEAN‐TAVI Investigators. Patients Refusing Transcatheter Aortic Valve Replacement Even Once Have Poorer Clinical Outcomes. J Am Heart Assoc. 2018 Sep 18;7(18):e009195. doi: 10.1161/JAHA.118.009195. PMID: 30371215
  4. Mizutani K, Hara M, Nakao M, Okai T, Kajio K, Murakami T, Shibata T, Yoshiyama M, Naganuma T, Yamanaka F, Higashimori A, Tada N, Takagi K, Araki M, Ueno H, Tabata M, Shirai S, Watanabe Y, Yamamoto M, Hayashida K. Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan. BMJ Open. 2018 Aug 17;8(8):e021468. doi: 10.1136/bmjopen-2017-021468. PMID: 30121598
  5. Arai T, Yashima F, Yanagisawa R, Tanaka M, Shimizu H, Fukuda K, Watanabe Y, Naganuma T, Araki M, Tada N, Yamanaka F, Shirai S, Yamamoto M, Hayashida K; OCEAN-TAVI investigators. Hospital readmission following transcatheter aortic valve implantation in the real world. Int J Cardiol. 2018 Oct 15;269:56-60. doi: 10.1016/j.ijcard.2018.07.073. Epub 2018 Jul 18. PMID: 30064926
  6. Yanagisawa R, Tanaka M, Yashima F, Arai T, Kohno T, Shimizu H, Fukuda K, Naganuma T, Mizutani K, Araki M, Tada N, Yamanaka F, Shirai S, Tabata M, Ueno H, Takagi K, Higashimori A, Watanabe Y, Yamamoto M, Hayashida K. Frequency and Consequences of Cognitive Impairmentin Patients Underwent Transcatheter Aortic Valve Implantation. Am J Cardiol. 2018 Sep 1;122(5):844-850. doi: 10.1016/j.amjcard.2018.05.026. Epub 2018 Jun 2. PMID: 30072128
  7. Shibata K, Yamamoto M, Kano S, Koyama Y, Shimura T, Kagase A, Yamada S, Kobayashi T, Tada N, Naganuma T, Araki M, Yamanaka F, Shirai S, Mizutani K, Tabata M, Ueno H, Takagi K, Higashimori A, Watanabe Y, Otsuka T, Hayashida K; on the behalf of OCEAN-TAVI investigators. Importance of Geriatric Nutritional Risk Index assessment in patients undergoing transcatheter aortic valve replacement. Am Heart J. 2018 Aug;202:68-75. doi: 10.1016/j.ahj.2018.04.021. Epub 2018 May 15. PMID: 29883896
  8. Miyasaka M, Tada N, Taguri M, Kato S, Enta Y, Otomo T, Hata M, Watanabe Y, Naganuma T, Araki M, Yamanaka F, Shirai S, Ueno H, Mizutani K, Tabata M, Higashimori A, Takagi K, Yamamoto M, Hayashida K; OCEAN-TAVI Investigators. Incidence, Predictors, and Clinical Impact of Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement in Asian Patients: The OCEAN-TAVI Registry. JACC Cardiovasc Interv. 2018 Apr 23;11(8):771-780. doi: 10.1016/j.jcin.2018.01.273. PMID: 29673509
  9. Kawashima H, Watanabe Y, Kozuma K, Kataoka A, Nakashima M, Hioki H, Nagura F, Nara Y, Shirai S, Tada N, Araki M, Naganuma T, Yamanaka F, Ueno H, Tabata M, Mizutani K, Higashimori A, Takagi K, Yamamoto M, Hayashida K; OCEAN-TAVI Investigators. Comparison of midterm outcomes of transcatheter aortic valve implantation in patients with and without previous coronary artery bypass grafting. Heart Vessels. 2018 Oct;33(10):1229-1237. doi: 10.1007/s00380-018-1166-9. Epub 2018 Apr 21. PMID: 29680865
  10. Hioki H, Watanabe Y, Kozuma K, Yamamoto M, Naganuma T, Araki M, Tada N, Shirai S, Yamanaka F, Higashimori A, Mizutani K, Tabata M, Takagi K, Ueno H, Hayashida K; OCEAN-TAVI Investigators. Effect of Serum C-Reactive Protein Level on Admission to Predict Mortality After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2018 Jul 15;122(2):294-301. doi: 10.1016/j.amjcard.2018.04.005. Epub 2018 Apr 12. PMID: 29735216
  11. Honda Y, Yamawaki M, Araki M, Tada N, Naganuma T, Yamanaka F, Watanabe Y, Yamamoto M, Shirai S, Hayashida K; OCEAN-TAVI investigators. Impact of HAS-BLED score to predict trans femoral transcatheter aortic valve replacement outcomes. Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1387-1396. doi: 10.1002/ccd.27596. Epub 2018 Mar 30. PMID: 29602206
  12. Hosoba S, Yamamoto M, Shioda K, Sago M, Koyama Y, Shimura T, Kagase A, Tada N, Naganuma T, Araki M, Yamanaka F, Shirai S, Watanabe Y, Hayashida K. Safety and efficacy of minimalist approach in transfemoral transcatheter aortic valve replacement: insights from the Optimized transCathEter vAlvular interventioN-Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry. Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):420-424. doi: 10.1093/icvts/ivx355. PMID: 29096029
  13. Hioki H, Watanabe Y, Kozuma K, Yamamoto M, Naganuma T, Araki M, Tada N, Shirai S, Yamanaka F, Higashimori A, Mizutani K, Tabata M, Takagi K, Ueno H, Hayashida K; OCEAN-TAVI Investigators. Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1365-1373. doi: 10.1002/ccd.27547. Epub 2018 Feb 22. PMID: 29469953
  14. Kagase A, Yamamoto M, Shimura T, Kodama A, Kano S, Koyama Y, Tada N, Naganuma T, Araki M, Yamanaka F, Shirai S, Watanabe Y, Hayashida K. Impact of pre-procedural hyponatremia on clinical outcomes after transcatheter aortic valve replacement: A propensity-matched analysis. Catheter Cardiovasc Interv. 2018 Aug 1;92(2):E125-E134. doi: 10.1002/ccd.27483. Epub 2018 Jan 11. PMID: 29322611
 

2017年

  1. Kagase A, Yamamoto M, Shimura T, Kano S, Tsuzuki M, Kodama A, Koyama Y, Shibata K, Hara M, Tada N, Naganuma T, Araki M, Yamanaka F, Shirai S, Watanabe Y, Hayashida K. Sex-Specific Grip Strength After Transcatheter Aortic Valve Replacement in Elderly Patients. JACC Cardiovasc Interv. 2018 Jan 8;11(1):100-101. doi: 10.1016/j.jcin.2017.06.055. PMID: 29301641
  2. Yamawaki M, Iwasaki K, Araki M, Ito T, Ito Y, Tada N, Takagi K, Yamanaka F, Watanabe Y, Yamamoto M, Shirai S, Hayashida K; OCEAN-TAVI Registry. A proctoring system to manage the learning curve associated with the introduction of transcatheter aortic valve implantation in Japan. Heart Vessels. 2018 Jun;33(6):630-639. doi: 10.1007/s00380-017-1098-9. Epub 2017 Dec 11. PMID: 29230569
  3. Yamawaki M, Araki M, Ito T, Honda Y, Tokuda T, Ito Y, Ueno H, Mizutani K, Tabata M, Higashimori A, Tada N, Takagi K, Yamanaka F, Naganuma T, Watanabe Y, Yamamoto M, Shirai S, Hayashida K; OCEAN-TAVI Registry. Ankle-brachial pressure index as a predictor of the 2-year outcome after transcatheter aortic valve replacement: data from the Japanese OCEAN-TAVI Registry. Heart Vessels. 2018 Jun;33(6):640-650. doi: 10.1007/s00380-017-1096-y. Epub 2017 Dec 11. PMID: 29230568
  4. Hayashida K, Yamamoto M. Transapical Approach: Learn From the Past, Move Toward the Future. JACC Cardiovasc Interv. 2017 Dec 11;10(23):2423-2425. doi: 10.1016/j.jcin.2017.10.019. PMID: 29217005
  5. Yamamoto M, Shimura T, Hayashida K. Response by Yamamoto et al to Letter Regarding Article, “Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement”. Circulation. 2017 Nov 14;136(20):1987-1988. doi: 10.1161/CIRCULATIONAHA.117.030514. PMID: 29133536
  6. Shimura T, Yamamoto M, Kano S, Kagase A, Kodama A, Koyama Y, Otsuka T, Kohsaka S, Tada N, Yamanaka F, Naganuma T, Araki M, Shirai S, Mizutani K, Tabata M, Ueno H, Takagi K, Higashimori A, Watanabe Y, Hayashida K. Impact of frailty markers on outcomes after transcatheter aortic valve replacement: insights from a Japanese multicenter registry. Ann Cardiothorac Surg. 2017 Sep;6(5):532-537. doi: 10.21037/acs.2017.09.06. PMID: 29062750
  7. Ochiai T, Saito S, Yamanaka F, Shishido K, Tanaka Y, Yamabe T, Shirai S, Tada N, Araki M, Naganuma T, Watanabe Y, Yamamoto M, Hayashida K. Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation. Heart. 2018 Apr;104(8):644-651. doi: 10.1136/heartjnl-2017-311738. Epub 2017 Oct 6. PMID: 28986405
  8. Kano S, Yamamoto M, Shimura T, Kagase A, Tsuzuki M, Kodama A, Koyama Y, Kobayashi T, Shibata K, Tada N, Naganuma T, Araki M, Yamanaka F, Shirai S, Mizutani K, Tabata M, Ueno H, Takagi K, Higashimori A, Otsuka T, Watanabe Y, Hayashida K. Gait Speed Can Predict Advanced Clinical Outcomes in Patients Who Undergo Transcatheter Aortic Valve Replacement: Insights From a Japanese Multicenter Registry. Circ Cardiovasc Interv. 2017 Sep;10(9):e005088. doi: 10.1161/CIRCINTERVENTIONS.117.005088. PMID: 28916601
  9. Yashima F, Yamamoto M, Tanaka M, Yanagisawa R, Arai T, Shimizu H, Fukuda K, Watanabe Y, Naganuma T, Shirai S, Araki M, Tada N, Yamanaka F, Hayashida K. Transcatheter aortic valve implantation in patients with an extremely small native aortic annulus: The OCEAN-TAVI registry. Int J Cardiol. 2017 Aug 1;240:126-131. doi: 10.1016/j.ijcard.2017.01.076. PMID: 28606674
  10. Shimura T, Yamamoto M, Kagase A, Kodama A, Kano S, Koyama Y, Tada N, Takagi K, Araki M, Yamanaka F, Shirai S, Watanabe Y, Hayashida K. The incidence, predictive factors and prognosis of acute pulmonary complications after transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg. 2017 Aug 1;25(2):191-197. doi: 10.1093/icvts/ivx075. PMID: 28453816
  11. Hioki H, Watanabe Y, Kozuma K, Nara Y, Kawashima H, Nagura F, Nakashima M, Kataoka A, Yamamoto M, Naganuma T, Araki M, Tada N, Shirai S, Yamanaka F, Hayashida K; OCEAN-TAVI Investigators. Timing of Susceptibility to Mortality and Heart Failure in Patients With Preexisting Atrial Fibrillation After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2017 Nov 1;120(9):1618-1625. doi: 10.1016/j.amjcard.2017.07.061. Epub 2017 Jul 31. PMID: 28842144
  12. Mizutani K, Hara M, Iwata S, Murakami T, Shibata T, Yoshiyama M, Naganuma T, Yamanaka F, Higashimori A, Tada N, Takagi K, Araki M, Ueno H, Tabata M, Shirai S, Watanabe Y, Yamamoto M, Hayashida K. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry. J Am Heart Assoc. 2017 Jul 14;6(7):e006112. doi: 10.1161/JAHA.117.006112. PMID: 28710182
  13. Kataoka A, Watanabe Y, Kozuma K, Nara Y, Nagura F, Kawashima H, Hioki H, Nakashima M, Yamamoto M, Takagi K, Araki M, Tada N, Shirai S, Yamanaka F, Hayashida K; OCEAN-TAVI Investigators. Prognostic Impact of Low-Flow Severe Aortic Stenosis in Small-Body Patients Undergoing TAVR: The OCEAN-TAVI Registry. JACC Cardiovasc Imaging. 2018 May;11(5):659-669. doi: 10.1016/j.jcmg.2016.12.028. Epub 2017 May 17. PMID: 28528156
  14. Kawashima H, Watanabe Y, Kozuma K, Nara Y, Hioki H, Kataoka A, Yamamoto M, Takagi K, Araki M, Tada N, Shirai S, Yamanaka F, Hayashida K. Propensity-matched comparison of percutaneous and surgical cut-down approaches in transfemoral transcatheter aortic valve implantation using a balloon-expandable valve. EuroIntervention. 2017 Mar 20;12(16):1954-1961. doi: 10.4244/EIJ-D-16-00408. PMID: 27746402
  15. Naganuma T, Kawamoto H, Takagi K, Yabushita H, Mitomo S, Watanabe Y, Shirai S, Araki M, Tada N, Yamanaka F, Yamamoto M, Onishi H, Nakamura S, Higashimori A, Tabata M, Mizutani K, Ueno H, Hayashida K. Can we perform rotational atherectomy in patients with severe aortic stenosis? Substudy from the OCEAN TAVI Registry. Cardiovasc Revasc Med. 2017 Jul-Aug;18(5):356-360. doi: 10.1016/j.carrev.2017.02.018. Epub 2017 Feb 28. PMID: 28314673
  16. Shimura T, Yamamoto M, Kano S, Kagase A, Kodama A, Koyama Y, Tsuchikane E, Suzuki T, Otsuka T, Kohsaka S, Tada N, Yamanaka F, Naganuma T, Araki M, Shirai S, Watanabe Y, Hayashida K; OCEAN-TAVI Investigators. Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement. Circulation. 2017 May 23;135(21):2013-2024. doi: 10.1161/CIRCULATIONAHA.116.025630. Epub 2017 Mar 16. PMID: 28302751

 

2016年

  1. Yamamoto M, Shimura T, Kano S, Kagase A, Kodama A, Sago M, Tsunaki T, Koyama Y, Tada N, Yamanaka F, Naganuma T, Araki M, Shirai S, Watanabe Y, Hayashida K. Prognostic Value of Hypoalbuminemia After Transcatheter Aortic Valve Implantation (from the Japanese Multicenter OCEAN-TAVI Registry). Am J Cardiol. 2017 Mar 1;119(5):770-777. doi: 10.1016/j.amjcard.2016.11.019. Epub 2016 Dec 2. PMID: 28017301
  2. Nara Y, Watanabe Y, Kozuma K, Kataoka A, Nakashima M, Hioki H, Kawashima H, Nagura F, Shirai S, Tada N, Araki M, Naganuma T, Yamanaka F, Yamamoto M, Hayashida K.Incidence, Predictors, and Mid-Term Outcomes of Percutaneous Closure Failure After Transfemoral Aortic Valve Implantation Using an Expandable Sheath (from the Optimized Transcatheter Valvular Intervention [OCEAN-TAVI] Registry). Am J Cardiol. 2017 Feb 15;119(4):611-617. doi: 10.1016/j.amjcard.2016.11.009. Epub 2016 Nov 16. PMID: 27939382
  3. Arai T, Yashima F, Yanagisawa R, Tanaka M, Shimizu H, Fukuda K, Watanabe Y, Naganuma T, Araki M, Tada N, Yamanaka F, Shirai S, Yamamoto M, Hayashida K; OCEAN-TAVI investigators. Prognostic value of liver dysfunction assessed by MELD-XI scoring system in patients undergoing transcatheter aortic valve implantation. Int J Cardiol. 2017 Feb 1;228:648-653. doi: 10.1016/j.ijcard.2016.11.096. Epub 2016 Nov 10. PMID: 27883976
  4. Watanabe Y, Kozuma K, Hioki H, Kawashima H, Nara Y, Kataoka A, Nagura F, Nakashima M, Shirai S, Tada N, Araki M, Takagi K, Yamanaka F, Yamamoto M, Hayashida K. Pre-Existing Right Bundle Branch Block Increases Risk for Death After Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve. JACC Cardiovasc Interv. 2016 Nov 14;9(21):2210-2216. doi: 10.1016/j.jcin.2016.08.035. PMID: 27832846
  5. Kodama A, Yamamoto M, Shimura T, Kagase A, Koyama Y, Tada N, Takagi K, Araki M, Yamanaka F, Shirai S, Watanabe Y, Hayashida K. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry. Catheter Cardiovasc Interv. 2017 Sep 1;90(3):E55-E62. doi: 10.1002/ccd.26686. Epub 2016 Oct 27. PMID: 2778588
  6. Hioki H, Watanabe Y, Kozuma K, Nara Y, Kawashima H, Kataoka A, Yamamoto M, Takagi K, Araki M, Tada N, Shirai S, Yamanaka F, Hayashida K; OCEAN-TAVI investigators. Pre-procedural dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation increases risk of bleeding. Heart. 2017 Mar;103(5):361-367. doi: 10.1136/heartjnl-2016-309735. Epub 2016 Aug 18. PMID: 27540180
  7. Yashima F, Yamamoto M, Watanabe Y, Takagi K, Yamada Y, Inohara T, Yanagisawa R, Tanaka M, Arai T, Shimizu H, Jinzaki M, Kozuma K, Fukuda K, Suzuki T, Hayashida K. Impact of underfilling and overfilling in balloon-expandable transcatheter aortic valve implantation assessed by multidetector computed tomography: Insights from the Optimized CathEter vAlvular iNtervention (OCEAN-TAVI) registry. Int J Cardiol. 2016 Nov 1;222:738-744. doi: 10.1016/j.ijcard.2016.07.218. Epub 2016 Jul 29. PMID: 27521550
  8. Watanabe Y, Kozuma K, Hioki H, Kawashima H, Nara Y, Kataoka A, Shirai S, Tada N, Araki M, Takagi K, Yamanaka F, Yamamoto M, Hayashida K. Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Versus Without Active Cancer. Am J Cardiol. 2016 Aug 15;118(4):572-7. doi: 10.1016/j.amjcard.2016.05.052. Epub 2016 May 28. PMID: 27324159
  9. Yamamoto M, Shimura T, Kano S, Kagase A, Kodama A, Koyama Y, Watanabe Y, Tada N, Takagi K, Araki M, Shirai S, Hayashida K. Impact of preparatory coronary protection in patients at high anatomical risk of acute coronary obstruction during transcatheter aortic valve implantation. Int J Cardiol. 2016 Aug 15;217:58-63. doi: 10.1016/j.ijcard.2016.04.185. Epub 2016 May 4. PMID: 27179209
  10. Watanabe Y, Morice MC, Kozuma K, Yamamoto M, Kawashima H, Yashima F, Inohara T, Bouvier E, Arai T, Fukuda K, Lefèvre T, Hayashida K. Comparison of aortic annulus dimensions between Japanese and European patients undergoing transcatheter aortic valve implantation as determined by multi-detector computed tomography: results from the OCEAN-TAVI (Optimised transCathEter vAlvular interveNtion) registry and a European single-centre cohort, AsiaIntervention 2016;2:49-56.
  11. Inohara T, Hayashida K, Watanabe Y, Yamamoto M, Takagi K, Yashima F, Arai T, Shimizu H, Chevalier B, Lefèvre T, Fukuda K, Morice MC.Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries. Catheter Cardiovasc Interv. 2016 Apr;87(5):963-70. doi: 10.1002/ccd.26266. Epub 2015 Oct 22. PMID: 26489980
 

2015年

2015年10月22日

Title ：Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries.

Author ：猪原 拓 Taku INOHARA（平塚市民病院 循環器内科）

論文リンク ：PubMed別ウィンドウで開く